Infographic | February 14, 2022

Biologic Drug Product Outsourcing Drivers by Company Size

Source: ISR Reports

In Q3 2021, ISR surveyed 136 sponsors who outsource biologic drug product manufacturing to learn more about their primary reason for outsourcing. The data show that sponsors from large pharma tend to use CMOs to augment internal manufacturing capacity (71%) while sponsors from non-large pharma use CMOs for all manufacturing needs (66%). To learn more, follow the link to the Biologic Drug Product CDMO Benchmarking report preview.

VIEW THE INFOGRAPHIC!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: